Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 163   

Articles published

NVS 77.20 +0.47 (0.61%)
price chart
Here's What The Novartis AG (ADR) (NYSE:NVS) Deal Means For Conatus ...
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) just announced that it has inked a deal with pharma giant Novartis AG (ADR) (NYSE:NVS); a deal that will see the latter team up with the microcap on the development of a drug called Emricasan. It's a NASH ...
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) Updates On Collaboration Contract ...  Journal Transcript
Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus ...  Insider Monkey (blog)
Credit Suisse Downgrades Novartis AG (ADR) to Neutral
Brokerage firm Credit Suisse Downgrades its rating on Novartis AG (ADR)(NVS). The shares have been rated Neutral. Previously, the analysts had a Outperform rating on the shares.
Analyst Views on Price Target: Novartis AG (ADR) (NYSE:NVS)  Post Registrar
Stocks to Track Novartis AG (ADR) (NYSE:NVS), Lifelock Inc (NYSE:LOCK)  Wall Street 24
Novartis Considering Sale Of Alcon Unit After Mixed Q4 Results And Outlook
In perhaps the biggest news stemming from the report, Novartis noted is considering strategic options for the consumer eye care Alcon Division.
Novartis AG (ADR): Why NVS Stock Is Ready to Rebound  Income Investors
Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG ...
Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an exclusive cardiovascular disease treatment collaborative agreement with Novartis AG ...
Novartis in $1.6 bln deal for Ionis, Akcea drugs  MarketWatch
Novartis AG (ADR) (NYSE:NVS) Says A Picture Is Worth A Thousand Words
Through its Canadian unit, Novartis is using images to bring out stories about advanced melanoma. The company says that the idea behind its photo campaign is to spark a conversation around advanced melanoma and to highlight the journey of patients ...
Novartis AG (NYSE:NVS) Fights for Survival after Patent Expiration  TCC
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Why Novartis AG (ADR) (NYSE: NVS) and Boeing Co (NYSE: BA) are rising today
Novartis AG (ADR) (NYSE: NVS) stock opened positive this morning and rose over 1.5% on January 25th, 2017 (as of 10:00 AM EST; Source: Google finance).
Analysts Review on Earnings Estimates: Novartis AG (ADR) (NYSE:NVS)  Post Registrar
Novartis AG (ADR) (NVS) is Downgraded by Credit Suisse to Neutral
On the company's financial health, Novartis AG (ADR) reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Oct 25, 2016.
Novartis AG (ADR) (NYSE:NVS) target price raised to $71.91, issued a report ...  Breaking Finance News
Novartis AG (ADR) (NVS) is Downgraded by Berenberg to Hold
On the company's financial health, Novartis AG (ADR) reported $1.23 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Oct 25, 2016.
Analyst Review Alert on Price Target: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) plunged -1.50% during previous trade, a total of 5.42M shares exchanged hands compared with its average trading volume of 3.39M shares whereas its relative volume is 1.96.